Durable complete response to neoantigen-loaded dendritic-cell vaccine following anti-PD-1 therapy in metastatic gastric cancer

Neoantigens are ideal targets for dendritic cell (DC) vaccines. So far, only a few neoantigen-based DC vaccines have been investigated in clinical trials. Here, we reported a case of a patient with metastatic gastric cancer who received personalized neoantigen-loaded monocyte-derived dendritic cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Zengqing, Yuan, Yuan, Chen, Chao, Lin, Jing, Ma, Qiwang, Liu, Geng, Gao, Yan, Huang, Ying, Chen, Ling, Chen, Li-Zhu, Huang, Yu-Fang, Wang, Hailun, Li, Bo, Chen, Yu, Zhang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166775/
https://www.ncbi.nlm.nih.gov/pubmed/35661819
http://dx.doi.org/10.1038/s41698-022-00279-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166775/
https://www.ncbi.nlm.nih.gov/pubmed/35661819
http://dx.doi.org/10.1038/s41698-022-00279-3

Ejemplares similares